Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Klinicka Mikrobiologie a Infekcni Lekarstvi|February 16, 2022
[Hepatitis D screening is important in the Czech Republic as well]Petr Husa, Svatava Snopková, Petr HusaKlinicka Mikrobiologie a Infekcni Lekarstvi|February 16, 2022
[Dual or triple combination antiretrovirals?]Petr Husa, Svatava SnopkováKlinicka Mikrobiologie a Infekcni Lekarstvi|October 20, 2006
[Metabolic syndrome and HIV/AIDS disorder]Svatava Snopková, Petr HusaVnitrni Lekarstvi|October 12, 2023
Implications of highly suppressive treatment HIV infectionSvatava Snopková, Petr HusaCasopis Lekaru Ceskych|June 21, 2022
Current hepatitis C therapyPetr Husa, Svatava Snopková, Petr Husa MlKlinicka Mikrobiologie a Infekcni Lekarstvi|December 2, 2016
[Tenofovir alafenamide fumarate - a new generation of tenofovir]Svatava Snopková, Kateřina Havlíčková, Petr HusaKlinicka Mikrobiologie a Infekcni Lekarstvi|September 3, 2005
[Haemopoiesis defects in HIV/AIDS-anaemia.]Svatava Snopková, Miloslava Matýsková, Petr Husa, et al.Klinicka Mikrobiologie a Infekcni Lekarstvi|January 14, 2025
[Cytomegalovirus coinfection]Svatava Snopková, Radek Svačinka, David Vydrář, et al.Klinicka Mikrobiologie a Infekcni Lekarstvi|January 14, 2025
[Pneumocystis pneumonia]Svatava Snopková, Radek Svačinka, David Vydrář, et al.Klinicka Mikrobiologie a Infekcni Lekarstvi|August 16, 2013
[RILPIVIRINE -- a novel HIV-1 non-nucleoside reverse transcriptase inhibitor]Svatava Snopková, Kateřina Havlíčková, Pavel Polák, et al.Pageof 9